Genomic sequencing is moving into clinical care, but this technological advance threatens to outpace our ability to use it effectively in clinical practice and to address the associated health policy issues. A key issue is whether payers will cover sequencing and what evidence will be needed to document its value. The TRANSPERS (Ctr for Translational & Policy Research on Personalized Medicine) Center at UC San Francisco has just released a Policy Primer for Genomic Sequencing, the press release for which can be viewed here: http://tinyurl.com/owbzaya.
Dr. Kathryn Phillips, the Center’s Director and Founder, will be discussing UCSF’s work on current coverage policies for gene panels and the factors that determine positive or negative coverage decisions at the 6th Annual Personalized Medicine Conference, taking place in San Francisco on October 29-30, 2014. To request a brochure, visit: http://tinyurl.com/qg5fr4d or visit www.personalizedmedicinepartnerships.com for more information.